Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 68 citing Dimopoulos: High serum lactate dehydrogenase level as a marker for drug resistance and short.... (0.08 sec) 

Primary dexamethasone treatment of multiple myeloma

- bloodjournal.org [PDF] 
R Alexanian, MA Dimopoulos, K Delasalle, B Barlogie - Blood, 1992 - Am Soc Hematology
. reserved Hematology; all rights Copyright 2007 by The American Society of Suite 200, Washington DC
20036. semimonthly by the American Society of Hematology, 1900 M St, NW, Blood (print ISSN
0006-4971, online ISSN 1528-0020), ...
Cited by 273 - Related articles - All 5 versions

Prediction of response to erythropoietin treatment in chronic anemia of cancer [see …

- hematologylibrary.org [PDF] 
H Ludwig, E Fritz, C Leitgeb, M Pecherstorfer … - …, 1994 - bloodjournal.hematologylibrary.org
. reserved Hematology; all rights Copyright 2007 by The American Society of Suite 200, Washington DC
20036. semimonthly by the American Society of Hematology, 1900 M St, NW, Blood (print ISSN
0006-4971, online ISSN 1528-0020), ...
Cited by 203 - Related articles - BL Direct - All 4 versions

Predictive role of interphase cytogenetics for survival of patients with multiple …

- jcojournal.org
R Konigsberg, N Zojer, J Ackermann, E Kromer, … - Journal of Clinical …, 2000 - jcojournal.org
From the First Department of Internal Medicine, Divisions of Clinical Oncology, and Hematology and
Hemostesiology, and Departments of Dermatology and Pathology, University of Vienna; Department of
Internal Medicine I With Medical ...
Cited by 120 - Related articles - BL Direct - All 7 versions

Prognostic value of cytogenetics in multiple myeloma


C Seong, K Delasalle, K Hayes, D Weber, … - British journal of …, 1998 - interscience.wiley.com
Karyotypic studies of bone marrow were conducted in 79 previously untreated patients with multiple
myeloma who received a standard programme of chemotherapy. An abnormal karyotype was observed in 46%
of patients, virtually all showing ...
Cited by 93 - Related articles - BL Direct - All 4 versions

Primary plasma cell leukaemia


MA Dimopoulos, A Palumbo, KB Delasalle … - British journal of …, 1994 - interscience.wiley.com
Summary. Among 750 previously untreated patients with multiple myeloma, 27 (4%) presented with
plasma cell leukaemia. All but one patient had high tumour mass and, when compared with comparable
patients without leukaemia, more ...
Cited by 82 - Related articles - BL Direct - All 3 versions

Multiple myeloma: clinical review and diagnostic imaging

- rsna.org
EJC Angtuaco, ABT Fassas, R Walker, R Sethi, B … - Radiology, 2004 - radiology.rsna.org
Multiple myeloma (MM) is a malignant clonal neoplasm of plasma cells of B-lymphocyte origin that
commonly results in overproduction of large amounts of monoclonal immunoglobulins. Important
advances in the therapeutic ...
Cited by 83 - Related articles - BL Direct - All 4 versions

Prognostic factors in multiple myeloma


SV Rajkumar, PR Greipp - Hematology/oncology clinics of North America, 1999 - Elsevier
There is significant variation in the survival of patients with myeloma, and approximately 3% of
patients live longer than 10 years. 74 Prognostic factors are needed to identify groups of patients
with widely different survival ...
Cited by 71 - Related articles - BL Direct - All 8 versions

Review of 1027 patients with newly diagnosed multiple myeloma

- mayoclinicproceedings.com [PDF] 
RA Kyle, MA Gertz, TE Witzig, JA Lust, … - Mayo Clinic …, 2003 - mayoclinproc.highwire.org
From the Division of Hematology and Internal Medicine (RAK, MAG, TEW, JAL, MQL, AD, RF, SVR, PRG)
and Divi- sion of Biostatistics (JRO, DRL, MEP, TMT), Mayo Clinic, Rochester, Minn. This study was
supported by grant CA62242 from the ...
Cited by 51 - Related articles - BL Direct - All 12 versions

MDR-1 expression and response to vincristine, doxorubicin, and dexamethasone …

- ascopubs.org [PDF] 
JJ Cornelissen, P Sonneveld, M Schoester, … - Journal of Clinical …, 1994 - jco.ascopubs.org
Purpose: To assess whether the presence of enhanced multiple rug resistance (MDR)- 1 gene expression
in mul- tiple myeloma (MM) patients predicts survival, as well as response to vincristine,
doxorubicin, and dexametha- sane ...
Cited by 51 - Related articles - BL Direct - All 7 versions

Limited value of myeloablative therapy for late multiple myeloma

- hematologylibrary.org [PDF] 
R Alexanian, M Dimopoulos, T Smith, K … - …, 1994 - bloodjournal.hematologylibrary.org
. reserved Hematology; all rights Copyright 2007 by The American Society of Suite 200, Washington DC
20036. semimonthly by the American Society of Hematology, 1900 M St, NW, Blood (print ISSN
0006-4971, online ISSN 1528-0020), ...
Cited by 46 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google